Visuomotor prosthetic for paralysis - the objective of the proposed research is to obtain scientific knowledge of visuomotor transformations in posterior parietal cortex (PPC) and primary motor cortex…
Ended Cooperative Agreement Awarded Last action
- Award ID
- UG1EY032039
- Recipient
-
California Institute Of Technology UEI U2JMKHNS5TG4
- Awarding agency
-
National Eye Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $10,418,699
Award facts
- Assistance listing
- 93.867 Vision Research
- Completion date
- Funding
-
- $9,642,813.00 Federal
- $775,886.00 Non-federal
- Place of performance
- Pasadena, CA 91125, USA
Award details come from USAspending.gov.
Description
Visuomotor prosthetic for paralysis - the objective of the proposed research is to obtain scientific knowledge of visuomotor transformations in posterior parietal cortex (PPC) and primary motor cortex (M1) from tetraplegic subjects in a clinical trial to advance the development of neural prosthetics. We have shown in clinical trials conducted over the past 6 years that PPC can control neural prosthetics for assisting tetraplegic subjects. Other groups have concentrated on M1 and likewise find control for neural prosthetics. In our studies of PPC we have found that besides trajectory signals to move robotic limbs or control computer cursors, there are a plethora of visuomotor signals that represent intended movements of most of the body, movement goals, cognitive strategies, and even memory signals. Our central hypothesis is that PPC and M1 will encode visuomotor parameters in both similar and different ways, and that algorithms can be developed to leverage those signals from the two areas that are complimentary to improve prosthetic range and performance. Implants will be made in both M1 and PPC, enabling simultaneous recording in the same subjects, elevating concerns of comparing data from different labs collected in different individuals with different implants and different tasks. This central hypothesis will be tested in two broad aims, for which we have substantial preliminary data. Aim 1 will examine the control of the body by the two areas. IT is hypothesized that M1 will demonstrate strong specificity for the contralateral limb (implants will be made in the hand knob) whereas PPC will code movements for most of the body and on both contra and ipsilateral sides by leveraging its partially mixed encoding of parameters (subaim 1A). Whereas M1 is hypothesized to code spatial variables exclusively during attempted or imagined actions, IT is hypothesized that PPC also encodes cognitive spatial variables in task appropriate reference frames (subaim 1B). In subaim 1C we will examine how multiple body parts are combined in movement representations, hypothesizing that M1 and PPC will employ a diverse set of mechanisms including linear summation, non-linear combinations, and movement suppression expressed in different ways as a function of brain area and the specific movement set. Aim 2 will examine the temporal aspects of encoding in the two areas. In subaim 2A we will test the hypothesis that the neural dynamics during sustained periods of movement are largely unchanging in both areas. In subaim 2B we hypothesize that, during sequential movements, M1 codes only the ongoing movement whereas PPC codes both the current and subsequent movements. Finally, in subaim 2C we will examine the coding of movement speed, with the hypothesis that there are separate subspaces in both M1 and PPC for direction and speed of movement.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Amendment | $1,355,439 | $0 | |
| Amendment | $1,355,439 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $651,311 | $0 | |
| Amendment | $658,011 | $0 | |
| Amendment | $658,011 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $646,286 | $0 | |
| Amendment | $646,286 | $0 | |
| Amendment | $646,286 | $0 | |
| Amendment | $736,986 | $0 | |
| Amendment | $736,986 | $0 | |
| Amendment | $3,536 | $0 | |
| Amendment | $3,536 | $3,536 | |
| Amendment | $772,350 | $0 | |
| Original award | $772,350 | $772,350 |
Show all 20
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| Casa Colina Hospital And Centers For Healthcare | $56,100 | |
| University Of California, LOS Angeles | $247,110 | |
| University Of California, LOS Angeles | $84,889 | |
| Casa Colina Hospital And Centers For Healthcare | $38,238 | |
| University Of California, LOS Angeles | $85,005 | |
| Casa Colina Hospital And Centers For Healthcare | $38,288 | |
| University Of California, LOS Angeles | $42,620 | |
| Casa Colina Hospital And Centers For Healthcare | $38,512 | |
| University Of California, LOS Angeles | $103,198 |
Quick answers
Who received award UG1EY032039?
UG1EY032039 was awarded to California Institute Of Technology by National Eye Institute (National Institutes of Health) on May 1, 2021.
How much is award UG1EY032039 worth?
$10,418,699 has been obligated on UG1EY032039: $9,642,813 in federal funding and $775,886 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award